Literature DB >> 9538302

Amiodarone and the thyroid: a practical guide to the management of thyroid dysfunction induced by amiodarone therapy.

C M Newman1, A Price, D W Davies, T A Gray, A P Weetman.   

Abstract

Amiodarone induces predictable changes in thyroid function tests that are largely explicable in terms of the physiological effects of iodide excess and inhibition of deiodinase activity. Clinically relevant thyroid dysfunction is not uncommon during amiodarone therapy, and requires careful diagnosis and treatment. The diagnosis and management of thyrotoxicosis is probably best supervised by a specialist endocrinologist. Control of hypothyroidism can generally be achieved simply by the addition of T4 to the therapeutic regimen, ideally after an initial assessment by an endocrinologist. The frequency with which amiodarone causes thyroid and other complications serves to emphasize the need for rational prescribing and long-term cardiological follow up.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9538302      PMCID: PMC1728611          DOI: 10.1136/hrt.79.2.121

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  49 in total

Review 1.  Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology.

Authors:  M P Vanderpump; J A Ahlquist; J A Franklyn; R N Clayton
Journal:  BMJ       Date:  1996-08-31

2.  Amiodarone and thyroid hormone metabolism.

Authors:  W M Wiersinga; M D Trip
Journal:  Postgrad Med J       Date:  1986-10       Impact factor: 2.401

3.  Amiodarone-induced hyperthyroidism: assessment of the predictive value of biochemical testing and response to combined therapy using propylthiouracil and potassium perchlorate.

Authors:  H H Newnham; D J Topliss; B A Le Grand; N Chosich; R W Harper; J R Stockigt
Journal:  Aust N Z J Med       Date:  1988-02

4.  Radioactive iodine thyroid uptake in patients with amiodarone-iodine-induced thyroid dysfunction.

Authors:  E Martino; L Bartalena; S Mariotti; F Aghini-Lombardi; C Ceccarelli; F Lippi; M Piga; A Loviselli; L Braverman; M Safran
Journal:  Acta Endocrinol (Copenh)       Date:  1988-10

5.  Thyroid dysfunction during chronic amiodarone therapy.

Authors:  S G Albert; L E Alves; E P Rose
Journal:  J Am Coll Cardiol       Date:  1987-01       Impact factor: 24.094

6.  Effects of amiodarone on 5'-deiodination of thyroxine to tri-iodothyronine in rat myocardium.

Authors:  J A Ceppi; A A Zaninovich
Journal:  J Endocrinol       Date:  1989-06       Impact factor: 4.286

7.  Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management.

Authors:  M D Brennan; J A van Heerden; J A Carney
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

8.  Amiodarone: a common source of iodine-induced thyrotoxicosis.

Authors:  E Martino; F Aghini-Lombardi; S Mariotti; L Bartalena; L Braverman; A Pinchera
Journal:  Horm Res       Date:  1987

9.  Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases.

Authors:  E Martino; F Aghini-Lombardi; S Mariotti; L Bartalena; M Lenziardi; C Ceccarelli; G Bambini; M Safran; L E Braverman; A Pinchera
Journal:  Clin Endocrinol (Oxf)       Date:  1987-02       Impact factor: 3.478

10.  Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis. Comparison of two groups of patients with apparently normal thyroid glands.

Authors:  C Broussolle; X Ducottet; C Martin; Y Barbier; H Bornet; G Noel; J Orgiazzi
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

View more
  22 in total

Review 1.  Thyroid disease and the heart.

Authors:  A D Toft; N A Boon
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

2.  [Hypothyroidism due to amiodarone: importance of monitoring].

Authors:  R Casañ Fernández; O Juan Vidal
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

Review 3.  Thyrotoxic atrial fibrillation.

Authors:  Malvinder S Parmar
Journal:  MedGenMed       Date:  2005-01-04

4.  Cross-vendor evaluation of key user-defined clinical decision support capabilities: a scenario-based assessment of certified electronic health records with guidelines for future development.

Authors:  Allison B McCoy; Adam Wright; Dean F Sittig
Journal:  J Am Med Inform Assoc       Date:  2015-06-23       Impact factor: 4.497

5.  'White elephants' and a distinguished monkey - or the need for a proactive follow-up in amiodarone therapy.

Authors:  Chr van Tellingen
Journal:  Neth Heart J       Date:  2004-10       Impact factor: 2.380

Review 6.  Amiodarone-induced thyroid disorders: a clinical review.

Authors:  K C Loh
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

7.  Amiodarone-induced thyrotoxicosis: type 1 or type 2?

Authors:  Ahsan Khan; Amar Puttanna; Diana Raskauskiene
Journal:  BMJ Case Rep       Date:  2014-10-27

8.  Total thyroidectomy for medically refractory amiodarone-induced thyrotoxicosis.

Authors:  Ankit N Mehta; Raphaelle D Vallera; Chad R Tate; Rebecca A Sager; Brian J Welch
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-10

Review 9.  Effects of amiodarone therapy on thyroid function.

Authors:  Janna Cohen-Lehman; Peter Dahl; Sara Danzi; Irwin Klein
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

Review 10.  [Total thyroidectomy in patients with amiodarone-induced hyperthyroidism: when does the risk of conservative treatment exceed the risk of surgery?].

Authors:  C Meerwein; D Vital; M Greutmann; C Schmid; G F Huber
Journal:  HNO       Date:  2014-02       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.